BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 15054815)

  • 1. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders.
    Al-Mukhaizeem KA; Rosenberg A; Sherker AH
    Am J Hematol; 2004 Apr; 75(4):225-30. PubMed ID: 15054815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal hypertension and nodular regenerative hyperplasia in a patient with celiac disease.
    Biecker E; Trebicka J; Fischer HP; Sauerbruch T; Lammert F
    Z Gastroenterol; 2006 May; 44(5):395-8. PubMed ID: 16688657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodular regenerative hyperplasia of the liver. A review of 14 cases.
    Arvanitaki M; Adler M
    Hepatogastroenterology; 2001; 48(41):1425-9. PubMed ID: 11677979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature].
    Capron JP; Degott C; Bernuau J; Saint-Marc Girardin MF; Zafrani ES; Braillon A; Quénum C; Dhumeaux D; Benhamou JP
    Gastroenterol Clin Biol; 1983 Oct; 7(10):761-9. PubMed ID: 6628910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.
    Hartleb M; Gutkowski K; Milkiewicz P
    World J Gastroenterol; 2011 Mar; 17(11):1400-9. PubMed ID: 21472097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension.
    Bissonnette J; Généreux A; Côté J; Nguyen B; Perreault P; Bouchard L; Pomier-Layrargues G
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1336-40. PubMed ID: 22554152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic nodular regenerative hyperplasia in a patient with advanced carcinoid tumor.
    Al-Hamoudi WK; Pasieka JL; Urbanski SJ; Lee SS
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1083-5. PubMed ID: 19318967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of nodular regenerative hyperplasia of liver that mimicked primary biliary cirrhosis].
    Shim SG; Sohn JH; Lee JW; Chung YW; Paik CH; Kim JP; Jeon YC; Han DS; Hahm JS; Lee DH; Kee CS; Oh YH
    Korean J Hepatol; 2004 Dec; 10(4):313-8. PubMed ID: 15613807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic problems in nodular regenerative hyperplasia (nodular transformation) of the liver. Review of the literature and report of two cases.
    Trauner M; Stepan KM; Resch M; Ebner F; Pristautz H; Klimpfinger M
    Z Gastroenterol; 1992 Mar; 30(3):187-94. PubMed ID: 1590015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series.
    Morris JM; Oien KA; McMahon M; Forrest EH; Morris J; Stanley AJ; Campbell S
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):1001-5. PubMed ID: 20075739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis of 15 cases of liver nodular regenerative hyperplasia.
    Guo T; Qian J; Zhu L; Zhou W; Zhu F; Sun G; Fang X
    Cell Biochem Biophys; 2012 Nov; 64(2):115-21. PubMed ID: 22707296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic portal venopathy and related disorders of the liver.
    Chawla Y; Dhiman RK
    Semin Liver Dis; 2008 Aug; 28(3):270-81. PubMed ID: 18814080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
    Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
    Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the endothelial genes Notch1 and ephrinB2 in patients with nodular regenerative hyperplasia.
    Rothweiler S; Terracciano L; Tornillo L; Dill MT; Heim MH; Semela D
    Liver Int; 2014 Apr; 34(4):594-603. PubMed ID: 23870033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sinusoidal portal hypertension secondary to nodular regenerative hyperplasia of the liver].
    Gento Peña E; Martín Lorente JL; Echevarría Iturbe C; Pérez Alvarez JC; Sáez-Royuela F; López Morante A; Ojeda Giménez C
    Gastroenterol Hepatol; 1999 Apr; 22(4):183-5. PubMed ID: 10349789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncirrhotic portal hypertension and nodular regenerative hyperplasia of the liver in dogs with mucopolysaccharidosis type I.
    McEntee MF; Wright KN; Wanless I; DeVovo R; Schneider JF; Shull R
    Hepatology; 1998 Aug; 28(2):385-90. PubMed ID: 9696001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations.
    Dachman AH; Ros PR; Goodman ZD; Olmsted WW; Ishak KG
    AJR Am J Roentgenol; 1987 Apr; 148(4):717-22. PubMed ID: 3548283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic and histological problems in the diagnosis of nodular regenerative hyperplasia of the liver.
    Solis Herruzo JA; Duran A; Colina F; Santalla F; Garcia-Cabezudo J; Muñoz-Yagüe MT; Morillas JD
    Endoscopy; 1985 May; 17(3):105-8. PubMed ID: 3159566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M; Preiss JC; Loddenkemper C; Günther U; Somasundaram R; Siegmund B; Zeitz M
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.